ASCO is in the news for new cancer treatment guidelines and push for equal access to care. Founded 1964 by Ansfield, Bisel, Freckman, Goudsmit. Stay sharp.
New results from ASCO show daraxonrasib nearly doubles median survival for pancreatic cancer, signaling a potential shift in how Ras-mutant cancers are treated. Trials also highlight progress against head and neck cancers and bladder cancer with immunotherapy and targeted therapies.